Nabumetone
- Product NDC
- 67296-2137
- 11-digit product format
- 672962137
- Labeler code
- 67296
- Product ID
- 67296-2137_46acaa7e-b06b-ae3a-e063-6394a90ac9f5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Redpharm Drug
- Application
- ANDA078420
- Marketing category
- ANDA
- Marketing start
- 2019-06-26
- Substance
- NABUMETONE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nabumetone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NABUMETONE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LW0TIW155Z |
| Rxcui | 311892 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-2137-3 | Nabumetone | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67296-2137-3 | 67296213703 | 30 TABLET in 1 BOTTLE (67296-2137-3) | 30 tablet | 2019-06-26 | No | No | Current |